X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma
- PMID: 25034530
- DOI: 10.1007/s13277-014-2331-0
X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma
Abstract
Hepatitis B virus (HBV) DNA is prone to mutations because of the proofreading deficiencies of HBV polymerase. The postoperative prognostic value of HBV mutations in HBV X protein (HBx) gene was assessed in HBV associated hepatocellular carcinoma (HCC) patients. The HBx gene was amplified and sequenced, the HBV mutations was identified according to NCBI database ( http://www.ncbi.nlm.nih.gov/genome/5536 ). The relationship between the HBV mutations and HCC survival was compared. Survival curves were generated using the Kaplan-Meier method, and comparisons between the curves were made using the log-rank test. Multivariate survival analysis was performed using a Cox proportional hazards model. After adjusting for clinical characteristics, the following eight mutational sites were identified as statistically significant independent predictors of HCC survival: 1383, 1461, 1485, 1544, 1613, 1653, 1719, and 1753. In addition, the following four mutational sites were identified for their association with survival at a border-line significance level: 1527, 1637, 1674, and 1762/1764. A total of 12 mutations in HBx gene region were identified as independent predictors of postoperative survival in HCC patients. The analysis of HBV DNA mutations may help identify patient subgroups with poor prognosis and may help refine therapeutic decisions regarding HCC patients.
Similar articles
-
Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma.PLoS One. 2015 Jul 24;10(7):e0133393. doi: 10.1371/journal.pone.0133393. eCollection 2015. PLoS One. 2015. PMID: 26208136 Free PMC article.
-
miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.World J Gastroenterol. 2016 Jun 14;22(22):5183-92. doi: 10.3748/wjg.v22.i22.5183. World J Gastroenterol. 2016. PMID: 27298561 Free PMC article.
-
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.Clin Microbiol Infect. 2019 Jul;25(7):906.e1-906.e7. doi: 10.1016/j.cmi.2018.11.017. Epub 2018 Nov 23. Clin Microbiol Infect. 2019. PMID: 30472417
-
Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.World J Gastroenterol. 2014 Aug 14;20(30):10238-48. doi: 10.3748/wjg.v20.i30.10238. World J Gastroenterol. 2014. PMID: 25132741 Free PMC article. Review.
-
Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.World J Gastroenterol. 2011 Oct 14;17(38):4258-70. doi: 10.3748/wjg.v17.i38.4258. World J Gastroenterol. 2011. PMID: 22090781 Free PMC article. Review.
Cited by
-
rt269I Type of Hepatitis B Virus (HBV) Polymerase versus rt269L Is More Prone to Mutations within HBV Genome in Chronic Patients Infected with Genotype C2: Evidence from Analysis of Full HBV Genotype C2 Genome.Microorganisms. 2021 Mar 15;9(3):601. doi: 10.3390/microorganisms9030601. Microorganisms. 2021. PMID: 33803998 Free PMC article.
-
X region mutations of hepatitis B virus related to clinical severity.World J Gastroenterol. 2016 Jun 28;22(24):5467-78. doi: 10.3748/wjg.v22.i24.5467. World J Gastroenterol. 2016. PMID: 27350725 Free PMC article. Review.
-
Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma.Onco Targets Ther. 2016 Dec 2;9:7367-7372. doi: 10.2147/OTT.S121785. eCollection 2016. Onco Targets Ther. 2016. PMID: 27980426 Free PMC article.
-
Hepatitis B Virus X Protein and Hepatocarcinogenesis.Int J Mol Sci. 2016 Jun 14;17(6):940. doi: 10.3390/ijms17060940. Int J Mol Sci. 2016. PMID: 27314335 Free PMC article. Review.
-
Nonsynonymous C1653T Mutation of Hepatitis B Virus X Gene Enhances Malignancy of Hepatocellular Carcinoma Cells.J Hepatocell Carcinoma. 2022 May 3;9:367-377. doi: 10.2147/JHC.S348690. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 35535232 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical